NASDAQ: LGVN

Longeveron Inc.

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Longeveron Inc. (NASDAQ: LGVN): (1) pursuant and/or traceable to the Offering documents issued in connection with the Company’s initial public offering conducted on or about February 12, 2021 (the “IPO” or “Offering”); and/or (2) between February 12, 2021 and August 12, 2021, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 12, 2021.

If you purchased Longeveron securities and would like to join the action, please click “Join This Class Action.”

Class Period:Pursuant and/or traceable to the Longeveron's February 2021 initial public offering (the “IPO” or “Offering”) and/or between February 12, 2021 and August 12, 2021, inclusive
If you purchased Longeveron securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Details of the case:

According to the lawsuit, the IPO documents and defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that:

  • Lomecel-B, a cell-based therapy product which is derived from culture-expanded medicinal signaling cells that are sourced from the bone marrow of young healthy adult donors, was not as effective in treating aging frailty as defendants had led investors to believe;
  • accordingly, Lomecel-B’s clinical and commercial prospects with respect to aging frailty were overstated;
  • as a result of all the foregoing, Longeveron’s financial and business prospects were also overstated;
  • and as a result, the Company’s public statements were materially false and misleading at all relevant times.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Follow us on:
Company Name: Longeveron Inc.
Stock Symbol: LGVN
Class Period: Pursuant and/or traceable to the Longeveron's February 2021 IPO and/or between February 12, 2021 and August 12, 2021, inclusive
Court: United States District Court for the Southern District of Florida

Why Rosen Law

The Rosen Law Firm has been ranked among the top 4 law firms each year since 2013 for the number of successful securities class actions on behalf of investors. In 2019 alone, our firm recovered $438 million for investors.

Investors should carefully identify and select experienced counsel with a track record of success leading securities class actions. Often other firms issue press releases about class actions yet do not have comparable experience or resources.

Institutional Shareholders Services ranked the Rosen Law Firm # 1 for the number of securities class action recoveries in 2017.

The Rosen Law Firm represents investors throughout the globe. Our mission is to prosecute securities fraud class actions and protect shareholders’ rights.

Scroll to Top